The Wilderness Between Love and Loss

November 6, 2020 By Erika R. Whitehead

The loss of her aunt and uncle converged upon Victoria Bennett, an award-winning poet, author, and founder of the Wild Woman Press in the U.K., pushing her toward the eventual devastating reality of losing her mother, Maureen. Bennett had become painfully familiar with the finality of death. Seven years before she lost her mom, Bennett’s eldest sister…

The 17th Annual Mesothelioma Awareness Day

September 25, 2020 By Erika R. Whitehead

Tomorrow, Sept. 26, marks the 17th annual National Mesothelioma Awareness Day. It was established in 2004 to raise awareness about mesothelioma and increase funding for mesothelioma research. “It was started by a couple of members in our community,” says Maja Belamaric, director of communications and operations for the Mesothelioma Applied Research Foundation (Meso Foundation). “These…

Cryoablation Study for Mesothelioma Opening at UCLA

August 12, 2020 By Melissa Soria

Researchers at UCLA Jonsson Comprehensive Cancer Center will soon begin studying the pre-surgery use of cryoablation as a potential early adjuvant therapy for patients with pleural mesothelioma. The pilot study will measure immune system stimulation through local tumor infiltration in hopes of extending patient survival in the future. Cryoablation, also known as cryotherapy or cryosurgery, freezes…

Mesothelioma Clinical Trials Now Back on Course

August 11, 2020 By Melissa Soria

A number of treatment centers, such as Brigham and Women’s Hospital in Boston, delayed mesothelioma clinical trials at the start of the pandemic. Others, such as the Pacific Mesothelioma Center in Los Angeles, continued screening patients, but on a limited basis. Now, many mesothelioma clinical trials are resuming regular screening and enrollment measures for mesothelioma patients…

New Mesothelioma Clinical Trial Involves Keytruda

July 22, 2020 By Melissa Soria

Standard-of-care treatment for malignant mesothelioma could change significantly, depending upon the results of an upcoming clinical trial of two immunotherapy agents used in combination with chemotherapy. The clinical trial will involve pembrolizumab, also known by the brand name Keytruda and its synergy with ONCOS-102, a lesser-known, genetically modified adenovirus. Individually, both have shown modest efficacy for mesothelioma…

New study shows that mesothelioma therapies are underutilized in women

June 16, 2020 By Melissa Soria

A new study has found that #mesothelioma therapies are underutilized in women. A research team of specialists has uncovered a surprising underutilization of treatments for pleural mesothelioma cancer in women. Women were 15% less likely to receive aggressive mesothelioma surgery that has proven its worth in extending lives for this cancer, which has no definitive cure. They…

Immunotherapy/chemotherapy study shows promise at ASCO 2020

June 4, 2020 By Melissa Soria

A phase 2 immunotherapy clinical trial combining durvalumab, an immunotherapy drug, with standard treatment of Alimta (pemetrexed)/cisplatin has shown promising overall survival results.  The study enrolled 55 patients and showed a median survival of 20.1 months. Of those 55 patients, 31 demonstrated a partial response, and 22 had stable disease. Most frequently observed adverse events included fatigue, nausea, anemia, and constipation…

Coronavirus and Mesothelioma Victims

March 11, 2020 By Melissa Soria

Mesothelioma patients and their caregivers have to be extra vigilant during this time as a result of the fast-spreading Coronavirus. Here is what the CDC recommends to stay healthy: * Wash your hands with soap and water for at least 20 seconds. * Use alcohol-based sanitizer with at least 60% alcohol content. * Avoid touching…

New liquid biopsy test unveiled for mesothelioma

February 18, 2020 By Melissa Soria

Cellular Analytics, a biotechnology company in Ontario, Canada, has unveiled a novel liquid biopsy test for mesothelioma that could lead to more effective management of this rare cancer. The test has the potential to produce a much-earlier diagnosis of disease and the ability to personalize treatment and better predict a patient’s response to specific therapies.…

Asbestos in talc can increase the risk of mesothelioma

January 29, 2020 By Melissa Soria

Did you know that asbestos in talc can increase the risk of mesothelioma? Talc is used in food processing, and to make some supplements, pharmaceutical pills, gum, and rice. Consumer groups have also found it in crayons and children’s toys. Talc is also used in many cosmetics: lipstick, mascara, face powder, blush, eye shadow, and foundation.